Search details
1.
N6-methyladenosine induced miR-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1.
Mol Cancer
; 18(1): 181, 2019 12 10.
Article
in English
| MEDLINE | ID: mdl-31823788
2.
Retraction Note: N6-methyladenosine induced mir-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1.
Mol Cancer
; 22(1): 132, 2023 Aug 12.
Article
in English
| MEDLINE | ID: mdl-37573296
3.
Toxic epidermal necrolysis related to AP (pemetrexed plus cisplatin) and gefitinib combination therapy in a patient with metastatic non-small cell lung cancer.
Chin J Cancer
; 34(2): 94-8, 2015 Feb.
Article
in English
| MEDLINE | ID: mdl-25418188
4.
Pemetrexed and cisplatin combination with concurrent whole brain radiotherapy in patients with brain metastases of lung adenocarcinoma: a single-arm phase II clinical trial.
J Neurooncol
; 112(3): 461-6, 2013 May.
Article
in English
| MEDLINE | ID: mdl-23420398
5.
Global Trend in Research and Development of CDK4/6 Inhibitors for Clinical Cancer Therapy: A Bibliometric Analysis.
J Cancer
; 12(12): 3539-3547, 2021.
Article
in English
| MEDLINE | ID: mdl-33995631
6.
Management of Non-Small-Cell Lung Cancer Patients Initially Diagnosed With 1 to 3 Synchronous Brain-Only Metastases: A Retrospective Study.
Clin Lung Cancer
; 22(1): e25-e34, 2021 01.
Article
in English
| MEDLINE | ID: mdl-32839132
7.
Treatment Patterns and Survival Outcomes of Non-Small Cell Lung Cancer Patients Initially Diagnosed With Brain Metastases in Real-World Clinical Practice.
Front Oncol
; 10: 581729, 2020.
Article
in English
| MEDLINE | ID: mdl-33163410
8.
Nanoparticles (NPs)-Meditated LncRNA AFAP1-AS1 Silencing to Block Wnt/ß-Catenin Signaling Pathway for Synergistic Reversal of Radioresistance and Effective Cancer Radiotherapy.
Adv Sci (Weinh)
; 7(18): 2000915, 2020 Sep.
Article
in English
| MEDLINE | ID: mdl-32999837
9.
Enhancer-Driven lncRNA BDNF-AS Induces Endocrine Resistance and Malignant Progression of Breast Cancer through the RNH1/TRIM21/mTOR Cascade.
Cell Rep
; 31(10): 107753, 2020 06 09.
Article
in English
| MEDLINE | ID: mdl-32521278
10.
RYBP Inhibits Progression and Metastasis of Lung Cancer by Suppressing EGFR Signaling and Epithelial-Mesenchymal Transition.
Transl Oncol
; 10(2): 280-287, 2017 Apr.
Article
in English
| MEDLINE | ID: mdl-28254703
11.
Long noncoding RNA XIST promotes malignancies of esophageal squamous cell carcinoma via regulation of miR-101/EZH2.
Oncotarget
; 8(44): 76015-76028, 2017 Sep 29.
Article
in English
| MEDLINE | ID: mdl-29100288
12.
Establishment of an Adjusted Prognosis Analysis Model for Initially Diagnosed Non-Small-Cell Lung Cancer With Brain Metastases From Sun Yat-Sen University Cancer Center.
Clin Lung Cancer
; 18(3): e179-e186, 2017 05.
Article
in English
| MEDLINE | ID: mdl-28185793
13.
miR-200b regulates epithelial-mesenchymal transition of chemo-resistant breast cancer cells by targeting FN1.
Discov Med
; 24(131): 75-85, 2017 09.
Article
in English
| MEDLINE | ID: mdl-28972876
14.
Benefit from thoracic radiotherapy in patients with extensive-disease small-cell lung cancer with elevated lactate dehydrogenase.
Onco Targets Ther
; 9: 1095-103, 2016.
Article
in English
| MEDLINE | ID: mdl-27042102
15.
Comparing single-agent with doublet chemotherapy in first-line treatment of advanced non-small cell lung cancer with performance status 2: a meta-analysis.
Asia Pac J Clin Oncol
; 11(3): 253-61, 2015 Sep.
Article
in English
| MEDLINE | ID: mdl-25866140
16.
Blood-brain barrier permeability of gefitinib in patients with brain metastases from non-small-cell lung cancer before and during whole brain radiation therapy.
Oncotarget
; 6(10): 8366-76, 2015 Apr 10.
Article
in English
| MEDLINE | ID: mdl-25788260
17.
A systematic review of gemcitabine and taxanes combination therapy randomized trials for metastatic breast cancer.
Springerplus
; 3: 293, 2014.
Article
in English
| MEDLINE | ID: mdl-26034661
18.
Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo.
Drug Des Devel Ther
; 8: 1827-37, 2014.
Article
in English
| MEDLINE | ID: mdl-25336925
19.
Network meta-analysis of erlotinib, gefitinib, afatinib and icotinib in patients with advanced non-small-cell lung cancer harboring EGFR mutations.
PLoS One
; 9(2): e85245, 2014.
Article
in English
| MEDLINE | ID: mdl-24533047
20.
Chemotherapy with concurrent brain and thoracic radiotherapy in brain-only metastases of treatment naive small-cell lung cancer: a phase II study.
Med Oncol
; 29(3): 1687-92, 2012 Sep.
Article
in English
| MEDLINE | ID: mdl-21853344